Franklin Resources Inc Cardiff Oncology, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.01 - $7.58 $3.1 Million - $4.69 Million	-618,600 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.65 - $10.04 $139 - $210	-21 Reduced -0.0%	618,600 $4.11 Million
Q4 2020 Feb 10, 2021	BUY	$12.02 - $24.71 $7.44 Million - $15.3 Million	618,621 New	618,621 $11.1 Million

125

25.3M

866K

203K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $206M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.